Table 2.
Studies describing in vivo osteogenic differentiation of AF-derived cells
Cell source | Scaffold | Animal model | Ref. |
oAF-MSCs | Magnesium-enriched hydroxyapatite/collagen-based scaffold | Sheep model of sinus augumentation | [85] |
hAFSCs | Nanofibrous or solid walled scaffolds | Midsagittal incision made on the dorsa and two subcutaneous pockets created using blunt dissection on male outbred thymic nude mouse model (nu/nu) | [86] |
hAFSCs | Fibroin scaffolds compared to collagen and poly-D,L-lactic acid scaffolds | Dorsal mid-sagittal incision made on the dorsa and two subcutaneous pockets were created using blunt dissection male outbred rats | [89] |
hAFSCs | Microfibrous starch and poly(ε-caprolactone) scaffold | Subcutaneous implantation into the dorsal side of athymic female nude rats | [91] |
hAFSCs | Construct composed of collagen type I | Critical-sized rat calvarial defect after oral administration of phytoestrogen ferutinin | [93] |
hAFSCs | Biomaterial Skelite | Subcutaneous implantation in the back of CD-1 nu/nu mice | [38] |
MSCs: Mesenchymal stromal cells; AF-MSCs: MSCs isolated from amniotic fluid; AFSCs: Amniotic fluid stem cells.